UK Stock Market Today: FTSE 100 Futures Ease As Hotter Inflation Extends Rate Debate

The Morning Bull - UK Market Morning Update Thursday, 22 Oct 2026

UK markets are set for a cautious open, with sentiment pinned to a fresh inflation surprise rather than overseas moves. The single story today is simple. Hotter September prices are reshaping expectations for the Bank of England.

Headline inflation printed at 3.5% in September, the highest in 11 months, while core inflation reached 2.8%, its strongest level in six months. Factory gate prices rose 4.6% year on year, signaling upstream cost pressure that keeps the policy debate live.

Higher and stickier inflation means investors are reassessing how long borrowing costs may stay restrictive. That feeds directly into discounted valuations for rate-sensitive assets, and into margin assumptions for companies that cannot easily pass on rising input and wage costs.

The unresolved question is whether the Bank leans into this data with a tougher tone, or treats it as noise in a still-fragile demand backdrop. Upcoming UK business surveys and consumer confidence readings could quickly support or undercut today’s inflation-driven view.

Stocks to Watch Before the Opening Bell

Quilter (QLT)

Quilter reports a 30% rise in Q3 core net inflows to £2.9b, with assets under management and administration at £160.5b. Platform net inflows are up 25% and adviser productivity improved 9%. For a market wrestling with higher inflation, that kind of sticky client money gives you a read on how comfortable households feel putting cash to work.

SEGRO (SGRO)

SEGRO posts £70m of new headline rent contracted year to date, 32% higher, with occupancy at 94.7% and customer retention at 80%. UK rent reviews are seeing average uplifts of 43%. The property group is also planning a UK big box joint venture that could generate around £500m in net proceeds, while a Prologis takeover heads toward completion in 2027.

GSK (GSK)

GSK just closed an exclusive licence from HUTCHMED for cancer therapy HMPL-A830 outside Greater China. HUTCHMED will run Phase I, then GSK takes over later stage trials and commercial work. ViiV Healthcare, majority owned by GSK, is also showing five year real world data for HIV drug Cabenuva, with 77% of patients staying on treatment and only 1% virologic failure.

Top Movers

• Ashtead Technology Holdings (LSE:AT.) rose 14.72%.
• Watches of Switzerland Group (LSE:WOSG) gained 5.31% after RBC reiterated a sector perform rating and highlighted solid revenue prospects.
• Entain (LSE:ENT) added 4.18% amid renewed interest in AI-related growth potential within betting and gaming platforms.

Top Losers

• Halfords Group (LSE:HFD) fell 8.63% as heavier second half investment plans offset 7% like-for-like sales growth.
• Aberdeen Group (LSE:ABDN) declined 4.09% after Q3 showed higher assets, interactive investor inflows and confirmation of 2026 targets.
• 3i Group (LSE:III) declined 3.93% during a weaker FTSE 100 session linked to worries around portfolio holding Action.

On The Radar

For UK investors, the next few sessions hinge on fresh business and consumer sentiment data at home, alongside a dense run of Barclays, GSK and other heavyweight earnings.

• CBI Business Optimism Index, Thu 22 Oct. A Q4 reading pitched against the previous minus 36 and a forecast near minus 38 will show how far pricing power and investment appetite are adjusting to 3.5% inflation and higher wage growth.
• CBI Industrial Trends Orders, Thu 22 Oct. Order books compared with the prior minus 9 and expectations around minus 18 matter for FTSE industrials because weaker demand would sit awkwardly beside the 4.6% factory gate inflation print.
• GfK Consumer Confidence, Thu 22 Oct. The October gauge versus September's minus 13 and forecasts near minus 14 feeds directly into views on UK retail volumes and how much of the recent 3.7% pay growth translates into discretionary spending.
• UK Retail Sales, Fri 23 Oct. September monthly sales, set against a prior 0.5% rise and a consensus near a 0.1% decline, will shape expectations for listed grocers and general retailers on whether higher prices are biting into volumes.
• Barclays, Thu 22 Oct. Q3 results put the spotlight on net interest income and loan impairment charges, which together give a clear indication of how sticky UK inflation and higher borrowing costs are feeding through to household and corporate credit quality.
• GSK, Wed 28 Oct. Q3 figures will focus attention on revenue from key therapies and any margin detail, which matter for judging how well the pharmaceutical group is balancing R&D spending against pricing pressure in major markets.

Sector & Industry Watch

Oil and Gas: High prices meet changing UK mix

Oil and Gas has flattened over the past week after a strong month, with Brent above $110 and UK output shifting as BP prepares to leave the North Sea while independents like Harbour Energy and EnQuest expand abroad. Big groups such as Shell and BP are also keeping a tight grip on spending, with more cash steered to debt reduction, dividends and buybacks rather than new megaprojects.

The main trigger now is how UK policy toward North Sea taxation and new fields evolves, because that combination of tax take and project approvals shapes long term cash flow from London listed producers.

Real Estate: Warehouses resilient as rates stay punchy

Real Estate has inched higher over seven days, helped by SEGRO reporting occupancy close to full and strong rent uplifts on UK logistics and data centre space. That kind of pricing power matters when factory gate inflation is running at 4.6% and borrowing remains expensive, since higher rents can offset part of the hit from interest costs.

The key catalyst is Bank of England communication, with Governor Bailey’s speech and upcoming UK PMI data likely to influence how investors judge refinancing risk and property values across listed REITs.

Consumer Discretionary: Rate exposed spending still patchy

Consumer Discretionary has pushed higher over the last week after a softer year, with Domino’s Pizza Group and Watches of Switzerland updates sitting alongside a share price drop at Halfords and weakness in Malvern International. UK CPI at 3.5% and regular pay growth at 3.7% show that pay packets are only just keeping pace with price rises, so discretionary retailers remain closely tied to confidence around jobs and mortgages.

The swing factor is Friday’s UK Retail Sales release for September, which will give a clean read on how much higher prices are affecting volumes in categories from apparel to big ticket household items.

Pharmaceuticals & Biotech: GSK activity brightens healthcare tone

Pharmaceuticals & Biotech has gained ground over the week, helped by GSK closing its cancer therapy licence with HUTCHMED and presenting five year real world data on HIV treatment Cabenuva. Deal making alongside pipeline data gives investors more detail on potential future products at a time when broader UK risk appetite is being tested by higher inflation and rate expectations.

The next clear test is the upcoming Q3 reporting season for GSK and peers, where the focus will be how licensing, HIV treatments and other therapies show up in revenue mix and research spending.

Metals and Mining: Critical minerals story vs weaker month

Metals and Mining has retreated over both the past week and month, even as companies like Rainbow Rare Earths and Bradda Head Lithium highlight the push to secure rare earths and battery metals outside China. Portfolio updates from large investors point to mining as a drag recently, while projects tied to electric vehicles and data centres keep longer term interest alive.

The sector’s most important near term signal is the UK CBI Industrial Trends Orders survey and Friday’s UK Manufacturing PMI, since export and factory order readings help shape demand expectations for iron ore, copper and specialist minerals produced by London listed groups.

Build Your Perfect Portfolio

With UK inflation at 3.5% and rate pressure still front of mind, start by stress testing your ideas against this list of 229 resilient stocks with low risk scores.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com